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Background: Reducing myocardial free fatty acid (FFA) use and increasing glucose oxidation is theoretically more efficient and should lessen 
ischemia. Hyperinsulinemia stimulates this metabolic change, but clinically is usually accompanied by acute hyperglycemia, which may have 
deleterious effects. We hypothesized that hyperinsulinemic euglycemia (HE) but not hyperinsulinemic hyperglycemia (HH) would improve LV function 
during stress echo (DSE).
Methods: 36 non-diabetic subjects with normal LV function and coronary disease (CAD) awaiting revascularisation underwent 2 DSEs, one 
clamped and one control. Prior to one DSE they were randomized in a 2:1 ratio to have either an HE or an HH clamp. The DSE was then performed 
as normal in the steady state phase of the clamp. Digital images of the LV were acquired with tissue Doppler at each stage for offline analysis. 
Segmental peak systolic velocity (Vs) and LV ejection fraction (EF) were used to assess LV performance. Blood samples for insulin, c-peptide and FFA 
were taken.
Results: Both HE and HH clamps effectively lowered FFA concentrations, thereby promoting glucose use. The HE clamp resulted in improved LV 
performance at peak stress, measured by Vs and LV EF, but the HH clamp had no net effect (table 1).
Conclusions: Hyperinsulinemia improves LV function during DSE in subjects with significant CAD, but this benefit is not seen when hyperglycemia is 
also present. This provides supporting evidence that acute hyperglycemia is detrimental to ischemic myocardium.
Table 1: The Effects of HE and HH clamping on LV performance during stress echo. Mean (SEM),
Hyperinsulinemic Euglycemic Clamp Hyperinsulinemic Hyperglycemic Clamp
Control Clamp p (ctrl vs clamp) Control Clamp p (ctrl vs clamp)
Pre-DSE Glucose (mg/dl) 98.6 (2.9) 96.3 (2.9) ns 87.5 (2.9) 240 (8.8) <0.0001
Pre-DSE FFA (micromol/l) 399 (49) 92 (14) <0.0001 429 (65) 77.2 (22) 0.0003
Pre-DSE Insulin (pmol/l) 64.1 (8) 530.8 (34) <0.0001 85.8 (22) 378 (52) 0.0007
Peak DSE EF (%) 65 (1.3) 71.9 (1.2) <0.0001 69.1 (2.4) 66.3 (3.1) ns
Ischemic Segments Peak DSE Vs (cm/s) 7.1 (0.3) 7.9 (0.3) 0.0001 8.5 (0.5) 8.6 (0.6) ns
Non-ischemic Segments Peak DSE Vs (cm/s) 7.9 (0.3) 8.4 (0.3) 0.06 8.4 (0.4) 8.6 (0.4) ns
